Showing 501 - 520 results of 1,132 for search '"immunosuppression"', query time: 0.07s Refine Results
  1. 501
  2. 502
  3. 503

    Contextual Vulnerability Should Guide Fair Subject Selection in Xenotransplantation Clinical Trials by Gianna Strand

    Published 2023-03-01
    “…Multi-center research studies have found that moderate non-adherence to immunosuppression regimens is not directly associated with poor kidney transplant outcomes.…”
    Get full text
    Article
  4. 504
  5. 505

    Tacrolimus and mycophenolate mofetil in corticosteroid-resistant hepatitis secondary to tislelizumab: a case report by Chang Jiang, Shanxian Guo

    Published 2025-02-01
    “…Through this case, we hope to emphasize the importance of reasonably extending the use of immunosuppressants to avoid the recurrence of IRH and reduce the premature discontinuation of immunosuppressants. …”
    Get full text
    Article
  6. 506

    The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation by Chao Zhang, Shuo Wang, Cheng Yang, Ruiming Rong

    Published 2016-01-01
    “…Considering their strong immunosuppressive capability, MDSCs could become a prospective clinical regimen during transplantation tolerance induction, resulting in long-term graft survival with decreased or without immunosuppressive drugs. …”
    Get full text
    Article
  7. 507

    Use of Cyclosporine in Uterine Transplantation by Srdjan Saso, Karl Logan, Yazan Abdallah, Louay S. Louis, Sadaf Ghaem-Maghami, J. Richard Smith, Giuseppe Del Priore

    Published 2012-01-01
    “…Cyclosporine A (CsA) is an immunosuppressant widely used by transplant recipients. …”
    Get full text
    Article
  8. 508

    Immunotherapy of osteosarcoma based on immune microenvironment modulation by Heping Lian, Heping Lian, Jiakui Zhang, Shuna Hou, Shuang Ma, Jiachen Yu, Wei Zhao, Duoyi Zhao, Zhiyu Zhang

    Published 2025-01-01
    “…As an emerging oncological treatment, immunotherapy has shown potential in the clinical management of many tumors but has a poor response rate in osteosarcoma. The immunosuppressive microenvironment in osteosarcoma is the main reason for the ineffectiveness of immunotherapy, in which the low immune response rate of immune effector cells and the high activation of immunosuppressive cells contribute to this outcome. …”
    Get full text
    Article
  9. 509

    Clinical Implications for the Timely Diagnosis of Mycobacterium marinum in the Age of Biologic Therapy: A Case Report and Review of the Literature by Chris J. Lata, Kelle Edgar, Stephen Vaughan

    Published 2017-01-01
    “…The natural history of this infection can be altered if the host is immunosuppressed, leading to disseminated presentations. …”
    Get full text
    Article
  10. 510

    Successful Treatment of Pulmonary Arterial Hypertension in Systemic Sclerosis with Anticentriole Antibody by Yusho Ishii, Hiroshi Fujii, Koichiro Sugimura, Tsuyoshi Shirai, Yosuke Hoshi, Yoko Fujita, Yuko Shirota, Tomonori Ishii, Hiroaki Shimokawa, Hideo Harigae

    Published 2020-01-01
    “…In general, several vasodilators are used as therapeutic drugs for SSc-PAH, whereas immunosuppressive therapies are not. Here, we report the case of a 62-year-old female with anticentriole antibody-positive SSc-PAH treated with immunosuppressants and vasodilators. …”
    Get full text
    Article
  11. 511

    Myasthenia gravis and Lambert-Eaton myasthenic syndrome: treatment options and guidance for management during COVID-19 pandemic by A. Klimašauskienė, R. Bunevičiūtė

    Published 2020-06-01
    “…During the COVID-19 pandemic, MG/LEMS patients should continue ongoing treatment and are advised not to stop any immunosuppressive agents used. Altering or stopping an immunosuppressive agent may increase disease activity and/or MG exacerbation or crisis. …”
    Get full text
    Article
  12. 512

    Pneumonia by Listeria monocytogenes: A Common Infection by an Uncommon Pathogen by Theocharis Koufakis, Marianneta Chatzopoulou, Anastasios Margaritis, Maria Tsiakalou, Ioannis Gabranis

    Published 2015-01-01
    “…Infections by Listeria monocytogenes typically occur in infants, the elderly, pregnant women, and immunosuppressed subjects. Pulmonary infections in adults are extremely uncommon and only few reports can be found in the literature. …”
    Get full text
    Article
  13. 513

    Polymyositis-Dermatomyositis and Interstitial Lung Disease in Pregnant Woman Successfully Treated with Cyclosporine and Tapered Steroid Therapy by Saito Mayu, Sakiko Isojima, Yoko Miura, Shinichiro Nishimi, Mika Hatano, Takahiro Tokunaga, Ryo Takahashi, Keiko Koide, Yusuke Miwa

    Published 2019-01-01
    “…Polymyositis-dermatomyositis is extremely rare during pregnancy, and immunosuppressive therapy should be administered after carefully considering the effects on both the mother and fetus. …”
    Get full text
    Article
  14. 514

    Spontaneous Pneumomediastinum due to Anti-Melanoma Differentiation-Associated Protein 5 Requiring a Bilateral Lung Transplant by Amrit Singh Jhajj, James Hok Shun Yeung, Fergus To

    Published 2021-01-01
    “…In medical literature, aggressive immunosuppressive therapy has been the mainstay of anti-MDA5-associated SPM management. …”
    Get full text
    Article
  15. 515

    Prospective Study of BK Virus Infection in Patients with Inflammatory Bowel Disease by Virginia Flores, Belén Rodríguez-Sánchez, Ignacio Marín-Jiménez, Emilio Bouza, Luis Menchén, Patricia Muñoz

    Published 2014-01-01
    “…A clear impact of the immunosuppressive regimen on BKV infection could not be demonstrated.…”
    Get full text
    Article
  16. 516

    Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors by Mei Zhan, Mei Zhan, Qinran Long, Qinran Long, Jinhan He, Jinhan He, Jinhan He, Litao Huang, Bin Wu, Bin Wu, Haixia Xu, Li Mo, Ting Xu

    Published 2025-01-01
    “…By excluding patients influenced by glucocorticoids or immunosuppressants, ICI-DM was observed in 713 of 8,199 (8.70%) patients. …”
    Get full text
    Article
  17. 517

    Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians by Muhammad Abdul Mabood Khalil, Muhammad Ashhad Ullah Khalil, Taqi F. Taufeeq Khan, Jackson Tan

    Published 2018-01-01
    “…On the contrary, reducing or stopping immunosuppressive medications in these events can provoke a rejection. …”
    Get full text
    Article
  18. 518

    Dermatological Disorders following Liver Transplantation: An Update by Dipesh Kumar Yadav, Xue li Bai, Tingbo Liang

    Published 2019-01-01
    “…Patients undergoing liver transplantation (LT) are at a high risk of dermatological complications compared to the general population as a result of long-term use of immunosuppressant. However, the risk is not as high as other solid organ transplantations (SOT), particularly for skin cancer. …”
    Get full text
    Article
  19. 519

    Use of High-Flow Nasal Cannula Oxygen Therapy in a Pregnant Woman with Dermatomyositis-Related Interstitial Pneumonia by Tomohiro Shoji, Takeshi Umegaki, Kota Nishimoto, Natsuki Anada, Akiko Ando, Takeo Uba, Munenori Kusunoki, Kanako Oku, Takahiko Kamibayashi

    Published 2017-01-01
    “…In order to save the life of the patient, the use of combination therapy with immunosuppressants was necessary. The patient underwent emergency cesarean section and was immediately treated with immunosuppressants while continuing HFNC oxygen therapy. …”
    Get full text
    Article
  20. 520

    The changing landscape of treatment for acquired hemophilia A by Massimo Franchini, Daniele Focosi

    Published 2025-01-01
    “…Recent studies have renewed the interest towards the immunosuppressive agent rituximab for FVIII inhibitor eradication and have suggested a potential role for emicizumab for the prevention of bleeding in AHA patients. …”
    Get full text
    Article